Key result
Intravenous anesthetics and sugammadex were safely applied without inducing cardiac arrhythmia in a 17-month-old male with congenital long QT syndrome undergoing a cochlear implant.
Why the study?
Long QT syndrome can lead to malignant arrhythmia and sudden death, and several commonly used anesthetic drugs can prolong the QT interval.
Can intravenous anesthetics and sugammadex be safely used in a child with congenital long QT syndrome?
Case Report (n=1)
Can intravenous anesthetics and sugammadex be safely used in a child with congenital long QT syndrome?
Intravenous anesthetics and sugammadex reversal were safely applied without triggering arrhythmias in a pediatric patient with congenital long QT syndrome.
May be safe for reversal in this pediatric long QT case; leaves open need for comparative studies.
Long QT syndrome is an inherited disorder of the heart's electrical activity that may also be associated with malignant arrhythmia and cause sudden death. In addition to this inherited condition, several commonly used anesthetic drugs can prolong the QT interval. We present here a 17-month-old male patient who underwent general anesthesia for a cochlear implant. No cardiac arrhythmia was observed in the patient, whose muscle relaxant effect was reversed using sugammadex. The application of intravenous anesthetics was preferred to maintain anesthesia for this patient and was safely applied.
No takes yet. Share an insight, caveat, or question.
Yaman et al. (2021) conducted a case report in Congenital Long QT Syndrome (n=1). Intravenous anesthetics and sugammadex was evaluated on Cardiac arrhythmia. Intravenous anesthetics and sugammadex were safely applied without inducing cardiac arrhythmia in a 17-month-old male with congenital long QT syndrome undergoing a cochlear implant.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: